Press

AgaMatrix New WaveSense Presto and Pro Glocose Meters to Simplify Testing

Friday, June 6th, 2008
Original source of this article:
View this article at external source

New WaveSense Presto(TM) and Pro(TM) Glucose Meters to Simplify Testing

SALEM, N.H., June 6 /PRNewswire/ — The makers of the WaveSense(TM)
line of blood glucose monitoring products (AgaMatrix, Inc.) announce the
launch of the WaveSense Presto and WaveSense KeyNote Pro Blood Glucose
Monitoring Systems (BGMS). The Presto is a no code meter with premium
features that consumers can buy at a value price. The Pro is designed for
use in institutional settings with added features for increased safety.

The Presto has all the market-leading features of AgaMatrix’s first
product, the WaveSense KeyNote(R), but does not require coding and is
priced considerably less than no code products from the major brands. The
system also has improved ergonomics and a brighter backlit display. Like
the KeyNote, it requires a small sample size (0.5 microliters), is As Fast
As 1-2-3(R), and has alternate site testing. Presto builds on the existing
base of WaveSense customers that is expected to exceed 1,000,000 by this
fall.

“We are extremely excited to launch our first no code product in the
United States,” said Dave Conn, Chief Commercial Officer. “Following the
feedback we received from our users, the new Presto meets a growing market
need for an affordable system that also has high accuracy and is easy to
use. We are very proud of our progress and these new products are an
important transition for our company as we grow. Consumers will be able to
find the Presto in retail outlets this fall.”

In a recent clinical study, the Presto was shown to be extremely
accurate, as 93% of the results were within 10% of a lab standard*.

The WaveSense product portfolio consists of the KeyNote and KeyNote
Pro, for users who want a value meter, the Presto, for users who want a no
code meter, and the WaveSense Jazz(TM), for users who want a premium meter
for better control. All products uniquely feature WaveSense, a new
technology that personalizes each test to provide world class accuracy.

Marian Batts-Turner, MSN, RN, CDE, a leading diabetes educator who is a
faculty member of the Welch Center for Prevention, Epidemiology, and
Clinical Research, at Johns Hopkins University, said, “It’s great to see
that the company is listening to what diabetes educators and patients are
asking for — high accuracy systems that are more affordable and easier to
use. This is vital for improving patient care.”

About WaveSense

WaveSense is a line of products designed to improve the quality of
diabetes care by using a new technology that personalizes each test to
provide world class accuracy. It detects and corrects for many errors
caused by differences in blood samples and environmental conditions. The
company also makes Zero-Click(TM), a diabetes data management system
designed to simplify data download. Together there are six FDA-cleared
products protected by a suite of more than 160 patents worldwide. For more
information on or to buy WaveSense products, see http://www.wavesense.info.

* Based on an ISO 15197 system accuracy study; Type 1 & Type 2
participants, YSI reference. Result is for reference concentrations greater
than or equal to 75 mg/dL. Laboratory Standard is a Yellow Springs
Instrument (YSI) 2300 STAT Plus Blood Glucose Analyzer.

WaveSense; Presto; Pro; KeyNote; WaveSense Jazz; and Zero-Click are
trademarks of AgaMatrix, Inc.

SOURCE WaveSense